Christina Rossi
About Christina Rossi
Company and Role of Christina Rossi
Christina Rossi currently serves as the Chief Operating Officer. With over 20 years of global pharmaceutical and biotechnology experience, she plays a pivotal role in the company's operations. Her past roles include serving as Chief Commercial Officer from October 2018 to April 2022. In her current role, she continues to influence strategy and operational excellence.
Christina Rossi's Experience in Pharmaceutical and Biotechnology
Christina Rossi's career spans over two decades in the pharmaceutical and biotechnology sectors. She has held numerous influential positions, including the Multiple Sclerosis (MS) Business Unit Head, North America, at Sanofi Genzyme, where she managed the financial performance and market share growth for the MS franchise. Additionally, she has overseen commercial launches and market access efforts for key therapies such as AYVAKIT (avapritinib) and GAVRETO (pralsetinib).
Notable Achievements by Christina Rossi
During her tenure as Chief Commercial Officer, Christina Rossi oversaw the successful commercial launches of AYVAKIT (avapritinib) and GAVRETO (pralsetinib) across various indications and geographies. She established comprehensive commercial infrastructures and spearheaded market access initiatives in both the U.S. and Europe. At Sanofi Genzyme, she significantly increased market share for existing MS therapies and facilitated the launch of new treatments.
Education and Expertise of Christina Rossi
Christina Rossi holds a Bachelor of Science degree in biology, cum laude, from Duke University and an MBA from Harvard Business School. Her academic foundation in biology and advanced business training have been crucial in her roles, providing a blend of scientific knowledge and strategic business acumen.
Board Membership and Consulting Roles of Christina Rossi
Christina Rossi currently serves as an independent director on the board of Xilio Therapeutics, where she is also a member of the compensation committee. Earlier in her career, she provided consultation for the healthcare practice at the Boston Consulting Group, adding to her diverse portfolio of leadership and strategic advisory roles across the healthcare sector.